Previous studies depict that high levels of IL-7 and IL-7R expression is associated with lymph node metastasis, poor survival, and poor prognosis in breast, lung, and prostate cancers. This evidence concerns the gene IL7 and metastatic malignant neoplasm in the lymph nodes.